Sean Laaman
Stock Analyst at Morgan Stanley
(4.83)
# 445
Out of 4,491 analysts
549
Total ratings
67.9%
Success rate
18%
Average return
Main Sectors:
Stocks Rated by Sean Laaman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EXEL Exelixis | Maintained: Hold | $50 | $57.04 | -12.34% | 18 | Jul 6, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintained: Hold | $26 | $26.08 | -0.31% | 11 | Jun 26, 2026 | |
| ABSI Absci | Rated: Hold | $4.1 → $10 | $11.51 | -13.12% | 8 | Jun 25, 2026 | |
| ARGX argenx SE | Rated: Buy | $1,170 → $1,180 | $920.52 | +28.19% | 10 | Jun 24, 2026 | |
| MPLT MapLight Therapeutics | Reiterated: Buy | $34 | $38.60 | -11.91% | 5 | Jun 22, 2026 | |
| IRON Disc Medicine | Rated: Buy | $80 → $85 | $81.14 | +4.76% | 12 | Jun 16, 2026 | |
| HALO Halozyme Therapeutics | Maintained: Buy | $93 | $81.58 | +14.00% | 18 | Jun 15, 2026 | |
| CGEM Cullinan Therapeutics | Maintained: Buy | $30 | $18.55 | +61.77% | 9 | Jun 7, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $94 → $98 | $90.74 | +8.00% | 6 | May 27, 2026 | |
| DNLI Denali Therapeutics | Maintained: Buy | $35 | $26.92 | +30.01% | 8 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 | $71.09 | +30.82% | 13 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $9.16 | +96.61% | 4 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 → $17 | $16.56 | +2.66% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $5.5 | $3.82 | +43.98% | 4 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $16 | $15.72 | +1.78% | 8 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $22 | $15.81 | +39.15% | 2 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $389 → $395 | $305.26 | +29.40% | 10 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $120 → $119 | $59.83 | +98.90% | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $185 → $191 | $179.26 | +6.55% | 17 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $226 → $245 | $249.96 | -1.98% | 15 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $217 → $242 | $247.61 | -2.27% | 9 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $0.9 → $2 | $1.77 | +12.99% | 5 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $10 → $12 | $19.36 | -38.02% | 6 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $11.25 | +184.44% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $40 | $33.31 | +20.08% | 4 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.30 | $2.87 | +14.98% | 19 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $6.64 | n/a | 1 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.80 → $3.95 | $5.04 | n/a | 22 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $207.62 | n/a | 13 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33.70 | $30.31 | n/a | 16 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $310.00 | $126.16 | n/a | 68 | Jun 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33.60 → $31.65 | $21.36 | n/a | 34 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25.38 → $24.14 | $31.57 | n/a | 18 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $26.18 → $28.14 | $40.25 | n/a | 5 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $276.00 → $256.00 | $123.68 | n/a | 21 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $1.30 | $0.39 | n/a | 29 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8.15 → $7.35 | $7.22 | n/a | 21 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.45 → $1.65 | $0.70 | n/a | 15 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47.49 → $46.27 | $22.15 | n/a | 10 | Jan 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $53.60 → $51.60 | $43.02 | n/a | 27 | Nov 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $2.70 → $2.75 | $2.06 | n/a | 13 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $15.22 | n/a | 2 | Aug 24, 2021 |
Exelixis
Jul 6, 2026
Maintained: Hold
Price Target: $50
Current: $57.04
Upside: -12.34%
ACADIA Pharmaceuticals
Jun 26, 2026
Maintained: Hold
Price Target: $26
Current: $26.08
Upside: -0.31%
Absci
Jun 25, 2026
Rated: Hold
Price Target: $4.1 → $10
Current: $11.51
Upside: -13.12%
argenx SE
Jun 24, 2026
Rated: Buy
Price Target: $1,170 → $1,180
Current: $920.52
Upside: +28.19%
MapLight Therapeutics
Jun 22, 2026
Reiterated: Buy
Price Target: $34
Current: $38.60
Upside: -11.91%
Disc Medicine
Jun 16, 2026
Rated: Buy
Price Target: $80 → $85
Current: $81.14
Upside: +4.76%
Halozyme Therapeutics
Jun 15, 2026
Maintained: Buy
Price Target: $93
Current: $81.58
Upside: +14.00%
Cullinan Therapeutics
Jun 7, 2026
Maintained: Buy
Price Target: $30
Current: $18.55
Upside: +61.77%
BridgeBio Pharma
May 27, 2026
Maintained: Buy
Price Target: $94 → $98
Current: $90.74
Upside: +8.00%
Denali Therapeutics
May 26, 2026
Maintained: Buy
Price Target: $35
Current: $26.92
Upside: +30.01%
May 15, 2026
Maintained: Buy
Price Target: $93
Current: $71.09
Upside: +30.82%
May 15, 2026
Maintained: Buy
Price Target: $18
Current: $9.16
Upside: +96.61%
May 14, 2026
Maintained: Hold
Price Target: $19 → $17
Current: $16.56
Upside: +2.66%
May 14, 2026
Maintained: Hold
Price Target: $5 → $5.5
Current: $3.82
Upside: +43.98%
May 14, 2026
Maintained: Hold
Price Target: $14 → $16
Current: $15.72
Upside: +1.78%
May 14, 2026
Maintained: Buy
Price Target: $20 → $22
Current: $15.81
Upside: +39.15%
May 7, 2026
Maintained: Buy
Price Target: $389 → $395
Current: $305.26
Upside: +29.40%
May 6, 2026
Rated: Buy
Price Target: $120 → $119
Current: $59.83
Upside: +98.90%
May 6, 2026
Reiterated: Hold
Price Target: $185 → $191
Current: $179.26
Upside: +6.55%
May 5, 2026
Maintained: Buy
Price Target: $226 → $245
Current: $249.96
Upside: -1.98%
May 5, 2026
Rated: Hold
Price Target: $217 → $242
Current: $247.61
Upside: -2.27%
May 4, 2026
Maintained: Sell
Price Target: $0.9 → $2
Current: $1.77
Upside: +12.99%
Mar 16, 2026
Maintained: Hold
Price Target: $10 → $12
Current: $19.36
Upside: -38.02%
Mar 3, 2026
Maintained: Buy
Price Target: $32
Current: $11.25
Upside: +184.44%
Feb 26, 2026
Maintained: Hold
Price Target: $40
Current: $33.31
Upside: +20.08%
Aug 28, 2025
Maintained: Buy
Price Target: $3.30
Current: $2.87
Upside: +14.98%
Jul 2, 2025
Initiated Coverage: Hold
Price Target: $16
Current: $6.64
Upside: n/a
Feb 12, 2025
Maintained: Hold
Price Target: $3.80 → $3.95
Current: $5.04
Upside: n/a
Aug 1, 2024
Rated: Hold
Price Target: n/a
Current: $207.62
Upside: n/a
Jun 24, 2024
Maintained: Buy
Price Target: $33.70
Current: $30.31
Upside: n/a
Jun 12, 2024
Maintained: Buy
Price Target: $310.00
Current: $126.16
Upside: n/a
May 22, 2024
Maintained: Buy
Price Target: $33.60 → $31.65
Current: $21.36
Upside: n/a
Apr 9, 2024
Maintained: Hold
Price Target: $25.38 → $24.14
Current: $31.57
Upside: n/a
Mar 22, 2024
Maintained: Hold
Price Target: $26.18 → $28.14
Current: $40.25
Upside: n/a
Mar 21, 2024
Maintained: Sell
Price Target: $276.00 → $256.00
Current: $123.68
Upside: n/a
Feb 28, 2024
Maintained: Sell
Price Target: $1.30
Current: $0.39
Upside: n/a
Feb 27, 2024
Maintained: Hold
Price Target: $8.15 → $7.35
Current: $7.22
Upside: n/a
Feb 26, 2024
Maintained: Buy
Price Target: $1.45 → $1.65
Current: $0.70
Upside: n/a
Jan 12, 2024
Maintained: Buy
Price Target: $47.49 → $46.27
Current: $22.15
Upside: n/a
Nov 28, 2023
Maintained: Hold
Price Target: $53.60 → $51.60
Current: $43.02
Upside: n/a
Aug 28, 2023
Maintained: Sell
Price Target: $2.70 → $2.75
Current: $2.06
Upside: n/a
Aug 24, 2021
Maintained: Buy
Price Target: n/a
Current: $15.22
Upside: n/a